Chronic Wound Care Market Size & Share, by Type (Pressure, Diabetic, Venous Leg, Other Ulcers); Product (Advanced Wound Dressings, Wound Care Devices, Active Therapy); End-user (Hospitals, Homecare Settings, Ambulatory Centers, Wound Care Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4450
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Chronic Wound Care Landscape

    • Smith & Nephew PLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ölnlycke Health Care AB
    • ConvaTec, Inc.
    • Integra LifeSciences Corporation
    • Coloplast A/S
    • Cardinal Health, Inc.
    • Tissue Regenix Ltd
    • B. Braun Melsungen AG
    • MIMEDX, Inc.
    • 3M

Browse Key Market Insights with Data Illustration:


In The News

  • Smith & Nephew PLC has announced the efficiency of its GRAFIX Membrane which reduces diabetic foot ulcer recurrence by half as compared to other leading competitors.

  • Integra LifeSciences Corporation announced the positive clinical outcomes with its PriMatrix Dermal Repair Scaffold for the treatment of hard-to-heal diabetic foot ulcers (DFUs). This is the largest DFU RCT ever conducted. A per protocol analysis found that 60% of DFUs healed within 12 weeks when PriMatrix was used in conjunction with standard care (SOC), compared to 35% for DFUs that healed within 12 weeks when SOC was used.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4450
  • Published Date: Feb 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Upsurge in chronic wound cases, high prevalence of chronic diseases, and increase in burn injuries are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of 10% over the forecast period, i.e., 2023-2033.

High cost of treatment of chronic wound, inadequate compensation policies in emerging nations, and rising concern in patients for urgent treatments are estimated to hamper the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Smith & Nephew PLC, ölnlycke Health Care AB, ConvaTec, Inc., Integra LifeSciences Corporation, Coloplast A/S, Cardinal Health, Inc., Tissue Regenix Ltd, B. Braun Melsungen AG, MIMEDX, Inc., 3M, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by end-user, type, product, and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying